Show simple item record

dc.contributor.authorBrett, Laura Jane
dc.date.accessioned2015-09-08T14:30:00Z
dc.date.available2015-09-08T14:30:00Z
dc.date.issued2014-05-23
dc.identifier.citationBrett, LJ. 2014. Study of Eryptosis in Patients with Renal Disease. Queen Mary University of Londonen_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/8538
dc.descriptionPhDen_US
dc.description.abstractEryptosis (erythrocyte programmed cell death) is postulated to be related to the efficacy of erythropoietin (Epo) treatment in chronic kidney disease (CKD) patients. This project was undertaken to determine whether this is the case and if any other factors correlate with eryptosis levels. Red cell microparticle (RCMP) numbers in whole blood were determined as a measure of eryptosis, using flow cytometry adapted from previous methods. Further investigation was performed using a flow loop model involving perfusion of whole blood through intact tumour necrosis factor (TNF) treated and untreated human umbilical arteries. Contrary to expectations, fewer RCMP were observed in CKD patients compared to controls (p=0.0167). Weak positive correlations were found between RCMP numbers and both CRP levels (p=0.0362) and Epo dose (p=0.0014) in the patient group. These results suggest erythrocytes in CKD patients undergo less eryptosis than in control subjects. In vitro investigations imply that erythrocytes in patients are less susceptible to the impact of flow stress and TNF treated endothelium than controls, corroborating this argument. When patients receiving Epo were compared to patients not receiving Epo there were no significant differences in RCMP numbers under all flow conditions. Further investigations are required, including the recruitment of more Epo hyporesponsive patients. This study highlighted the need for better standardisation of methods for measuring not only RCMP, but eryptosis in general, as well as better definitions of RCMP populations.en_US
dc.description.sponsorshipDepartment of Immunophenotyping, Barts Health NHS Trust; Cardiovascular and Inflammation Biology Research Group,Royal Veterinary Collegeen_US
dc.language.isoenen_US
dc.publisherQueen Mary University of Londonen_US
dc.subjectHaematologyen_US
dc.subjectRenal diseaseen_US
dc.subjectErythrocyte programmed cell deathen_US
dc.subjectKidney diseaseen_US
dc.titleStudy of Eryptosis in Patients with Renal Diseaseen_US
dc.typeThesisen_US
dc.rights.holderThe copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Theses [2958]
    Theses Awarded by Queen Mary University of London

Show simple item record